BioCentury
ARTICLE | Clinical News

Critics continue to pile on as CRISPR researcher describes informed consent, review process

November 28, 2018 10:09 PM UTC

Jiankui He outlined the peer review and informed consent process used in the first-ever human CRISPR germline gene editing trial at the International Summit on Human Genome Editing on Wednesday. However, critics decried the process as irresponsible and opaque, while a consensus statement from the research community on next steps is expected tomorrow.

In response to questions about the ethics of the trial and review process, He said he sought input in advance on the trial design, including review by a bioethicist at Stanford University. ...



Access The Full Article